Health Catalyst Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	302.48	311.14	306.58	295.94	276.24	241.93
Revenue Growth	-2.83%	1.49%	3.60%	7.13%	14.18%	28.11%
Cost of Revenue	151.58	159.46	165.81	164.11	143.05	124.35
Gross Profit	150.9	151.68	140.78	131.83	133.19	117.57
Selling, General & Admin	97.68	102.04	111.2	143.88	149.22	160.96
Depreciation & Amortization Expenses	50.3	50.5	41.43	42.22	48.3	37.53
Research & Development	44.36	49.77	57.95	72.63	75.68	62.73
Other Operating Expenses	205.72	110.22	-	-	-	-
Total Operating Expenses	398.06	312.53	210.59	258.73	273.19	261.22
Operating Income	-247.16	-160.85	-69.81	-126.9	-140.01	-143.65
Total Non-Operating Income (Expense)	-17.18	-16.4	0.64	9.11	-1.68	-16.46
Pretax Income	-264.34	-177.26	-69.17	-117.79	-141.68	-160.11
Provision for Income Taxes	-0.09	-0.72	-0.33	-0.36	4.28	6.9
Net Income	-265.26	-177.97	-69.5	-118.15	-137.4	-153.21
Net Income to Common	-265.26	-177.97	-69.5	-118.15	-137.4	-153.21
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	71	70	60	56	54	47
Shares Outstanding (Diluted)	71	70	60	56	54	47
Shares Change	13.13%	16.13%	6.68%	4.32%	13.87%	20.12%
EPS (Basic)	-3.72	-2.55	-1.15	-2.09	-2.56	-3.23
EPS (Diluted)	-3.72	-2.55	-1.15	-2.09	-2.63	-3.23
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	18.33	-0.24	12.94	-34.32	-37.44	-33.57
Free Cash Flow Growth	634.51%	-	-	-	-	-
Free Cash Flow Per Share	0.26	-0.00	0.22	-0.61	-0.69	-0.71
Gross Margin	49.89%	48.75%	45.92%	44.55%	48.21%	48.60%
Operating Margin	-81.71%	-51.70%	-22.77%	-42.88%	-50.68%	-59.38%
Profit Margin	-87.69%	-57.20%	-22.67%	-39.92%	-49.74%	-63.33%
FCF Margin	6.06%	-0.08%	4.22%	-11.60%	-13.55%	-13.88%
EBITDA	-196.87	-110.35	-28.38	-84.67	-91.71	-106.12
EBITDA Margin	-65.08%	-35.47%	-9.26%	-28.61%	-33.20%	-43.87%
EBIT	-247.16	-160.85	-69.81	-126.9	-140.01	-143.65
EBIT Margin	-81.71%	-51.70%	-22.77%	-42.88%	-50.68%	-59.38%
Effective Tax Rate	0.03%	0.40%	0.48%	0.30%	-3.02%	-4.31%

SEC Filings: 10-K · 10-Q